Silent myocardial infarction diagnosed by myocardial perfusion SPECT in a young woman with systemic lupus erythematosus

[1]  J. Morrow,et al.  Drugs to Treat Systemic Lupus Erythematosus: Relationship between Current Use and Cardiovascular Risk Factors , 2008, Archives of drug information.

[2]  M. Cerinic,et al.  Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases , 2005, Circulation.

[3]  E. Borba,et al.  Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus? , 2004, Arthritis and rheumatism.

[4]  I. Bruce,et al.  Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. II. Predictive factors for perfusion abnormalities. , 2003, The Journal of rheumatology.

[5]  A. Hamsten,et al.  Risk Factors for Cardiovascular Disease in Systemic Lupus Erythematosus , 2001, Circulation.

[6]  I. Bruce,et al.  Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. I. Prevalence and distribution of abnormalities. , 2000, The Journal of rheumatology.

[7]  J. Ramires,et al.  Chylomicron metabolism is markedly altered in systemic lupus erythematosus. , 2000, Arthritis and rheumatism.

[8]  R. D'Agostino,et al.  Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. , 1997, American journal of epidemiology.

[9]  F. Pileggi,et al.  Lipoprotein(a) levels in systemic lupus erythematosus. , 1994, The Journal of rheumatology.

[10]  D. Isenberg,et al.  Fasting lipids and anticardiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosus. , 1992, Annals of the rheumatic diseases.

[11]  L. Kuller,et al.  Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. , 1999, Arthritis and rheumatism.